Entegris insiders and growth funds sold $1.4 billion while Stifel made the AI case
Stifel just made the AI-materials case for Entegris with a $200 target. The filings show insiders and growth funds selling about $1.4 billion of stock into the same rally, with the quarter that settles it due October 29.
Vincent Jiang · 3 min read
Entegris walks into its October 29 earnings print with two stories running at once, and they do not agree. The public ledger: Stifel initiated coverage on October 7 with a Buy and a $200 target, 21 percent above the $166.32 close, arguing the company's advanced materials earn more per wafer as leading-edge logic, memory and packaging capacity expands. Analyst Brian Chin models a higher growth phase in 2027-28 with EPS growth above 30 percent and calls the stock undervalued at a PEG ratio under 0.85 5. The company's own quarter backs him up. Revenue hit $883.2 million in the period ended June 27, up 11.5 percent year over year and 5.5 percent above consensus, with adjusted EPS of $0.93 up 40.9 percent and adjusted gross margin at 47.6 percent, the best since early 2022 47. Q3 guidance runs $905 million to $935 million in sales and $0.96 to $1.04 in EPS 6.
Revenue hit a record $883.2 million, up 11.5 percent, the fastest growth in two years
Data
| Revenue | |
|---|---|
| Q3 '24 | 807.7 |
| Q4 '24 | 849.8 |
| Q1 '25 | 773.2 |
| Q2 '25 | 792.4 |
| Q3 '25 | 807.1 |
| Q4 '25 | 823.9 |
| Q1 '26 | 811.9 |
| Q2 '26 | 883.2 |
Growth funds sold $1.43 billion in the quarter that beat
The filing ledger is not bullish. Insiders sold 13 times over the past six months and bought zero, led by executive chair Bertrand Loy, who sold 61,534 shares for roughly $8.8 million; across six executives, about $16.3 million left the stock 1. The growth funds that rode the re-rating cashed out in the same Q2 that produced the beat: Lone Pine Capital sold its entire 3.1 million share stake, about $560 million, Cantillon Capital cut its position by 95.4 percent, about $372 million, and Barrow Hanley halved its position, about $498 million 1. Against that, JPMorgan's book added 5.5 million shares, a roughly $993 million position, and Representative April McClain Delaney bought ENTG in 8 of her 9 trades over six months, worth up to $120,000, in the same quarter the company disclosed $90,000 of lobbying on CHIPS Act implementation, export controls and the Chip EQUIP Act 1.
Three growth funds sold about $1.43 billion of Entegris in the same quarter as the beat
Data
| Value | |
|---|---|
| Lone Pine Capital | $560M |
| Barrow Hanley | $498M |
| Cantillon Capital | $372M |
The market has already voted once on this story, and not the way the bulls tell it. The stock is up 12.2 percent since the August 4 report but had fallen 9.8 percent in the month after the beat, underperforming the S&P 500, before the October re-rating lifted it again 48. At $166.32 it sits below the $186.94 52-week high, and the consensus mean target of $177.06 implies just 6.5 percent upside, with 2 of 18 analyst recommendations still sells 8.
Who wins on October 29
The setup leaves no cushion. Consensus looks for $1.02 of adjusted EPS on $923.8 million of revenue, and guidance says $0.96 to $1.04, so even a midpoint result is already in the price of a stock that has nearly doubled year to date 56. If the quarter holds, the AI-materials thesis Stifel just wrote down gets its proof. If guided EPS slips, the flow says the best-informed holders, the ones who sold $1.43 billion of growth-fund paper and $16 million of insider stock, got out first. Two dates settle it: the October 29 release at 8:00 a.m. ET and the November 9 Investor Day in New York 36.
Deepdive
AI-generated from this story and its cited sources. Not investment advice.



